Insmed Incorporated - Common Stock (INSM) stock analysis

INSM · Insmed Incorporated - Common Stock

Latest recorded price: USD 122.88

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 35.2%, free cash flow margin -159.6%, ROIC -708.0%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare